Gotowa bibliografia na temat „Toxic hepatitis”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Toxic hepatitis”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Toxic hepatitis"
Peker, Erdal, Eren Cagan i Murat Dogan. "Ceftriaxone-induced toxic hepatitis". World Journal of Gastroenterology 15, nr 21 (2009): 2669. http://dx.doi.org/10.3748/wjg.15.2669.
Pełny tekst źródłaDierckx, R. I. R., i M. F. J. Vandewoude. "DONEPEZIL-RELATED TOXIC HEPATITIS". Acta Clinica Belgica 63, nr 5 (październik 2008): 339–42. http://dx.doi.org/10.1179/acb.2008.066.
Pełny tekst źródłaTopal, Firdevs, Ersan Özaslan, Sabiye Akbulut, Metin Küçükazman, Osman Yüksel i Emin Altiparmak. "Methylprednisolone-Induced Toxic Hepatitis". Annals of Pharmacotherapy 40, nr 10 (październik 2006): 1868–71. http://dx.doi.org/10.1345/aph.1h171.
Pełny tekst źródłaBaum, Susan L., i Anthony J. Suruda. "Toxic Hepatitis from Dimethylacetamide". International Journal of Occupational and Environmental Health 3, nr 1 (styczeń 1997): 1–4. http://dx.doi.org/10.1179/oeh.1997.3.1.1.
Pełny tekst źródłaLança, Sara, Amanda Alves, Ana Isabel Vieira, José Barata, João de Freitas i Álvaro de Carvalho. "Chromium-induced toxic hepatitis". European Journal of Internal Medicine 13, nr 8 (grudzień 2002): 518–20. http://dx.doi.org/10.1016/s0953-6205(02)00164-4.
Pełny tekst źródłaCicognani, Camilla, Mauro Malavolti, Antonio Maria Morselli-Labate, Claudia Sama i Luigi Barbara. "Flutamide-induced toxic hepatitis". Digestive Diseases and Sciences 41, nr 11 (listopad 1996): 2219–21. http://dx.doi.org/10.1007/bf02071403.
Pełny tekst źródłaYang, Ha Na, Dong Joon Kim, Young Mook Kim, Byoung Ho Kim, Kyoung Min Sohn, Myung Jin Choi i Young Hee Choi. "Aloe-induced Toxic Hepatitis". Journal of Korean Medical Science 25, nr 3 (2010): 492. http://dx.doi.org/10.3346/jkms.2010.25.3.492.
Pełny tekst źródłaSheikh, Israr, i Joan Culpepper-Morgan. "Sorrel Induced Toxic Hepatitis". American Journal of Gastroenterology 110 (październik 2015): S884—S885. http://dx.doi.org/10.14309/00000434-201510001-02117.
Pełny tekst źródłaAydın, Mesut. "Toxic hepatitis due to heliz". Van Medical Journal 28, nr 1 (2021): 15–18. http://dx.doi.org/10.5505/vtd.2021.02328.
Pełny tekst źródłaAhn, Byung-Min. "Medicinal Herbs and Toxic Hepatitis". Journal of the Korean Medical Association 48, nr 4 (2005): 318. http://dx.doi.org/10.5124/jkma.2005.48.4.318.
Pełny tekst źródłaRozprawy doktorskie na temat "Toxic hepatitis"
Zhou, Ting. "Isoniazid hepatotoxicity". Thesis, University of British Columbia, 1990. http://hdl.handle.net/2429/29456.
Pełny tekst źródłaMedicine, Faculty of
Anesthesiology, Pharmacology and Therapeutics, Department of
Graduate
Митус, Н. В., i К. І. Чепілко. "Токсичні гепатити в практиці інфекціоніста". Thesis, Видавництво СумДУ, 2011. http://essuir.sumdu.edu.ua/handle/123456789/15035.
Pełny tekst źródłaМедвідь, І. І., i Л. С. Фіра. "Досліджування впливу густого екстракту з листя шовковиці (Morus alba, Morus nigra) на метаболічні порушення у тварин з токсичним гепатитом". Thesis, Видавництво СумДУ, 2011. http://essuir.sumdu.edu.ua/handle/123456789/14470.
Pełny tekst źródłaLenga, E. L. "Effects of melatonin on the content of reduced glutation in the blood under toxic hepatitis". Thesis, БДМУ, 2020. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18371.
Pełny tekst źródłaWright, Paul F. A. "Systemic oxidant stress and its effects on hepatotoxicity /". Title page, contents and abstract only, 1988. http://web4.library.adelaide.edu.au/theses/09PH/09phw952.pdf.
Pełny tekst źródłaAlfaifi, Mohammed. "Cell therapy for acute liver injury : in vivo efficacy of mesenchymal stromal cells in toxic and immune-mediated murine hepatitis". Thesis, University of Birmingham, 2018. http://etheses.bham.ac.uk//id/eprint/8330/.
Pełny tekst źródłaПришляк, А. М., С. І. Яворська, Т. К. Головата i Б. Я. Ремінецький. "Стан вільнорадикальних процесів організму щурів та морфологічні зміни в товстій кишці при змодельованому токсичному гепатиті". Thesis, Сумський державний університет, 2017. http://essuir.sumdu.edu.ua/handle/123456789/65580.
Pełny tekst źródłaHe, Wencan. "Etude du rôle de la Cytolethal Distending Toxin dans la carcinogenèse digestive et la survie cellulaire". Thesis, Bordeaux, 2020. http://www.theses.fr/2020BORD0087.
Pełny tekst źródłaHumans are frequently exposed to bacterial genotoxins, colibactin and Cytolethal Distending Toxin (CDT), involved in digestive cancers. These toxins damage the DNA of host cells and constitute a predisposing factor for the development of cancer. Enterohepatic Helicobacters, such as Helicobacter hepaticus and Helicobacter pullorum, are associated with several intestinal and hepatic diseases. Their main virulence factor is CDT.We studied the mechanisms of action of CDT genotoxin in the activation of pro-cancerous processes and cell survival, using Helicobacter hepaticus infection, as a model. We demonstrated that the nuclear remodeling induced by Helicobacter CdtB active subunit of CDT involves MAFB oncoprotein overexpression which is subsequently associated with a strong nuclear and perinuclear localization of MAFB protein in CDT/CdtB-distended nuclei, and with the formation of large lamellipodia, corresponding to cellular extensions known to be involved in cell migration and arousal of metastases. We also showed that the nuclear remodeling induced by CDT/CdtB could be associated to the formation of transient rich-messenger ribonucleoprotein nucleoplasmic reticulum (NR). These genotoxin-induced dynamic structures may correspond to a privileged gateway for the synthesis of selected mRNA, preferentially transported from the nucleus, through pores and translated therein. CDT-induced NR may allow the cell to pause and repair DNA damage caused by bacterial genotoxins in order to maintain cell survival. Microarray-based identification of differentially-expressed genes pointed a CdtB regulation of autophagy. We showed that CdtB stimulated autophagic flux and enhanced pro-survival autophagy following CDT-induced DNA damage. CDT promoted the formation of cytoplasmic SQSTM1/P62 aggregates, sometimes deeply invaginated in distended nuclei, as well as SQSTM1/P62-positive extra-cellular like vesicles. NR formation following DNA damage induced by CDT is associated with the induction of autophagy, which plays a survival role in this context. SQSTM1/P62 have a key role in these effects.These findings offer new insights into the context of NR formation and cell survival in response to DNA damage, a common feature of many cancers, which not only appears in response to therapies-induced DNA damage, but also earlier in response to genotoxic bacteria.Further studies are required identify the cytosolic structures surrounded and engulfed by P62/SQSTM1 and to decipher the role of this cargo protein in the prosurvival of cells whose DNA is damaged, and more particularly its role in NR formation in light with its recently demonstrated RNA-binding protein function.The results of this thesis support the idea that bacterial genotoxins could cause cancer
Wright, Paul F. A. (Paul Frank Albert). "Systemic oxidant stress and its effects on hepatotoxicity". 1988. http://web4.library.adelaide.edu.au/theses/09PH/09phw952.pdf.
Pełny tekst źródłaWright, Paul F. A. (Paul Frank Albert). "Systemic oxidant stress and its effects on hepatotoxicity / by Paul F.A. Wright". Thesis, 1988. http://hdl.handle.net/2440/18808.
Pełny tekst źródłaKsiążki na temat "Toxic hepatitis"
J, Manning Frederick, i Swartz Morton N, red. Review of the Fialuridine (FIAU) clinical trials. Washington, DC: National Academy Press, 1995.
Znajdź pełny tekst źródła1957-, Emanuel Ezekiel J., red. Exploitation and developing countries: The ethics of clinical research. Princeton, N.J: Princeton University Press, 2008.
Znajdź pełny tekst źródłaJean-Paul, Fillastre, Institut national de la santé et de la recherche médicale (France) i Université de Rouen. Centre du médicament, red. Hépatoxicité médicamenteuse. [Paris]: Editions INSERM, 1986.
Znajdź pełny tekst źródłaLeung, Doris G. Neuropathies Associated with Infection or Toxic Exposure. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0113.
Pełny tekst źródłaC, Sahu Saura, red. Hepatotoxicity: From genomics to in vitro and in vivo models. Chichester, England: John Wiley & Sons, 2007.
Znajdź pełny tekst źródłaLevy, Barry S. Liver Disorders. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190662677.003.0030.
Pełny tekst źródłaC, Sahu Saura, red. Hepatotoxicity: From genomics to in vitro and in vivo models. Chichester, England: John Wiley & Sons, 2007.
Znajdź pełny tekst źródłaHepatotoxicity: From Genomics to In Vitro and In Vivo Models. Wiley, 2008.
Znajdź pełny tekst źródłaSahu, Saura. Hepatotoxicity. Wiley & Sons, Incorporated, John, 2010.
Znajdź pełny tekst źródłaBrennfleck, Shannon Joyce, red. Liver disorders sourcebook: Basic consumer health information about the liver and how it works; liver diseases, including cancer, cirrhosis, hepatitis, and toxic and drug related diseases; tips for maintaining a healthy liver; laboratory tests, radiology tests, and facts about liver transplantation; along with a section on support groups, a glossary, and resources listings. Detroit, Mich: Omnigraphics, 2000.
Znajdź pełny tekst źródłaCzęści książek na temat "Toxic hepatitis"
Raj, Satish R., S. R. Wayne Chen, Robert S. Sheldon, Arti N. Shah, Bharat K. Kantharia, Ulrich Salzer, Bodo Grimbacher i in. "Toxic Hepatitis, Acute". W Encyclopedia of Molecular Mechanisms of Disease, 2095. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_45.
Pełny tekst źródłaScharnagl, Hubert, Winfried März, Markus Böhm, Thomas A. Luger, Federico Fracassi, Alessia Diana, Thomas Frieling i in. "Acute Toxic Hepatitis". W Encyclopedia of Molecular Mechanisms of Disease, 31. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_9020.
Pełny tekst źródłaStolz, Andrew. "Toxic and Drug-Induced Hepatitis". W Modern Concepts of Acute and Chronic Hepatitis, 201–15. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4615-9519-9_14.
Pełny tekst źródłaCioffi, William G., Michael D. Connolly, Charles A. Adams, Mechem C. Crawford, Aaron Richman, William H. Shoff, Catherine T. Shoff i in. "Toxin Induced Hepatitis". W Encyclopedia of Intensive Care Medicine, 2244. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_2309.
Pełny tekst źródłaKrichbaum, Michelle, i Maura Miller. "Pain Management in Liver Disease". W Pain, 345–52. Oxford University Press, 2022. http://dx.doi.org/10.1093/med/9780197542873.003.0041.
Pełny tekst źródłaM., Halima, Ihsana Banu Ishthiaq, Sneha Unnikrishnan i Karthikeyan Ramalingam. "Nanoemulsion-Based Antiviral Drug Therapy". W Handbook of Research on Nanoemulsion Applications in Agriculture, Food, Health, and Biomedical Sciences, 194–212. IGI Global, 2022. http://dx.doi.org/10.4018/978-1-7998-8378-4.ch009.
Pełny tekst źródłaOkwudiri Ihegboro, Godwin, i Chimaobi James Ononamadu. "Drug-Induced Hepatotoxicity". W Hepatotoxicity [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.103766.
Pełny tekst źródłaKayyal, Mohamad K. "Estimation of Amounts of Waste Generated from Healthcare Facilities". W Environmental Information Systems in Industry and Public Administration, 215–26. IGI Global, 2001. http://dx.doi.org/10.4018/978-1-930708-02-0.ch014.
Pełny tekst źródłaMarjot, Thomas. "Liver disorders". W Best of Five MCQS for the European Specialty Examination in Gastroenterology and Hepatology, 208–58. Oxford University Press, 2021. http://dx.doi.org/10.1093/oso/9780198834373.003.0008.
Pełny tekst źródłaLi, Jie Jack. "Sofosbuvir (Sovaldi)". W Top Drugs. Oxford University Press, 2015. http://dx.doi.org/10.1093/oso/9780199362585.003.0017.
Pełny tekst źródłaStreszczenia konferencji na temat "Toxic hepatitis"
Kudryavtsev, Vladimir, Anatoly Shatrov i Alexey Vishnyakov. "Mathematical modeling of toxic hepatitis in male Wistar rats". W 2022 IEEE International Multi-Conference on Engineering, Computer and Information Sciences (SIBIRCON). IEEE, 2022. http://dx.doi.org/10.1109/sibircon56155.2022.10016912.
Pełny tekst źródłaDzhioev, I. G., F. E. Batagova, O. V. Remizov, E. A. Gutsaeva i I. I. Akhmadov. "The Effect of the Course Intake of Hilak Mineral Water on Liver Function in Experimental Toxic Hepatitis and Intrahepatic Cholestasis". W Proceedings of the International Conference on Health and Well-Being in Modern Society (ICHW 2019). Paris, France: Atlantis Press, 2019. http://dx.doi.org/10.2991/ichw-19.2019.21.
Pełny tekst źródłaKondufor, O. V., i YA A. Sockaya. "Dynamics of the isoenzyme spectrum of lactate dehydrogenase in patients with chronic toxic hepatitis ethanol etiology in combination with cerebrovascular pathology". W SCIENCE OF RUSSIA: TARGETS AND GOALS. "Science of Russia", 2019. http://dx.doi.org/10.18411/sr-10-10-2019-14.
Pełny tekst źródłaRaporty organizacyjne na temat "Toxic hepatitis"
Gidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, Sydne J. Newberry, Peggy Chen, Kelsey O’Hollaren, Nabeel Qureshi i in. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), maj 2021. http://dx.doi.org/10.23970/ahrqepccer244.
Pełny tekst źródła